Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (111-120 of 508) with videos related to

Pageof 51
Sort By:
The American Journal of Cardiology|October 29, 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)Michael Böhm, Michele Robertson, Ian Ford, et al.
European Heart Journal|August 28, 2012
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registryPh Gabriel Steg, Nicola Greenlaw, Jean-Claude Tardif, et al.
European Thyroid Journal|August 13, 2014
The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than GoodDavid J Stott, Douglas C Bauer, Ian Ford, et al.
International Journal of Cardiology|September 19, 2012
Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery diseaseRoberto Ferrari, Hélène Abergel, Ian Ford, et al.
Circulation|July 15, 2021
International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY StudyJules Mesnier, Gregory Ducrocq, Nicolas Danchin, et al.
Cardiology|September 12, 2016
Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina PectorisJeffrey S Borer, Karl Swedberg, Michel Komajda, et al.
International Journal of Cardiology|May 28, 2013
Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study populationKim Fox, Marie-Germaine Bousser, Pierre Amarenco, et al.
European Journal of Preventive Cardiology|August 23, 2014
Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registryRoberto Ferrari, Ian Ford, Nicola Greenlaw, et al.
Atherosclerosis. Supplements|November 9, 2004
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995James Shepherd, Stuart M Cobbe, Ian Ford, et al.
Diabetes|March 31, 2007
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factorNaveed Sattar, Alex McConnachie, Ian Ford, et al.
Pageof 51

Showing results (111-120 of 508) with videos related to

Sort By:
Pageof 51
The American Journal of Cardiology|October 29, 2015
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial)Michael Böhm, Michele Robertson, Ian Ford, et al.
European Heart Journal|August 28, 2012
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registryPh Gabriel Steg, Nicola Greenlaw, Jean-Claude Tardif, et al.
European Thyroid Journal|August 13, 2014
The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than GoodDavid J Stott, Douglas C Bauer, Ian Ford, et al.
International Journal of Cardiology|September 19, 2012
Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery diseaseRoberto Ferrari, Hélène Abergel, Ian Ford, et al.
Circulation|July 15, 2021
International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY StudyJules Mesnier, Gregory Ducrocq, Nicolas Danchin, et al.
Cardiology|September 12, 2016
Efficacy Profile of Ivabradine in Patients with Heart Failure plus Angina PectorisJeffrey S Borer, Karl Swedberg, Michel Komajda, et al.
International Journal of Cardiology|May 28, 2013
Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study populationKim Fox, Marie-Germaine Bousser, Pierre Amarenco, et al.
European Journal of Preventive Cardiology|August 23, 2014
Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registryRoberto Ferrari, Ian Ford, Nicola Greenlaw, et al.
Atherosclerosis. Supplements|November 9, 2004
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. 1995James Shepherd, Stuart M Cobbe, Ian Ford, et al.
Diabetes|March 31, 2007
Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factorNaveed Sattar, Alex McConnachie, Ian Ford, et al.
Pageof 51